Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating efficacy and long-term safety of Ozanimod in Japanese patients with moderately to severely active ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
This clinical trial update reports long-term safety and efficacy data for Efavaleukin Alfa in adults with moderately to severely active Ulce…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update evaluating adverse events and changes in disease activity after intravenous or subcutaneous lutikizumab in adu…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
A South Korea–focused clinical trial update shows Vedolizumab SC is being studied in adults with moderate-to-severe Ulcerative Colitis or Cr…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) [Phase 3]
This is a completed Phase 3 study evaluating Vedolizumab in children and teenagers with moderate to severe ulcerative colitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
This clinical trial update reports Phase 3 results for mirikizumab in moderately to severely active ulcerative colitis. The study is current…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial of mirikizumab in moderately to severely active ulcerative colitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases [NA]
This completed clinical trial evaluated the medico-economic impact of therapeutic drug monitoring for anti-TNF-α therapy in inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants [Phase 1]
Mage Biologics conducted a Phase 1 safety study of an oral biologic in healthy participants; the trial for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Comparative Outcomes of Ulcerative Colitis Patients With Mayo Endoscopic Score 1 and Histologic Activity Versus Mayo Endoscopic Score 2
This completed clinical trial evaluates outcomes in ulcerative colitis patients with Mayo Endoscopic Score 1 and histologic activity versus …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Microbiota and Probiotic Therapy in Ulcerative Colitis Patients
This clinical trial update notes that the microbiota and probiotic therapy study in ulcerative colitis patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]
This is a completed special drug-use surveillance study of 300 mg intravenous vedolizumab for ulcerative colitis, with results posted on 202…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD [NA]
The clinical trial evaluating a fasting-mimicking diet for depressive symptoms in inflammatory bowel disease has completed. The study includ…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis [Phase 2]
Phase 2 study evaluating amiselimod (MT-1303) for mild to moderate ulcerative colitis has completed. The update does not provide efficacy or…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 update reporting long-term safety and efficacy data for ABX464 in adults with moderate-to-severe active ulcerative colitis; the stud…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
A real-world study in Poland evaluating Vedolizumab for adults with ulcerative colitis or Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Rutin Therapy Role in Reducing Ulcerative Colitis Severity [NA]
A completed clinical trial from Benha University evaluated rutin therapy for reducing the severity of ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis [Phase 2]
Phase 2 study of SPH3127 for mild to moderate ulcerative colitis has completed. This update confirms the Phase 2 trial status but does not p…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis [NA]
A clinical trial update describes an evaluation of vedolizumab combined with upadacitinib for ulcerative colitis, with study status currentl…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: SMART-IBD App Trial [NA]
ClinicalTrials.gov shows the SMART-IBD app trial for inflammatory bowel disease has completed; the sponsor is Children’s Hospital Medical Ce…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology [NA]
Clinical trial exploring tissue repair in inflammatory bowel disease using organoid technology. Recruitment is ongoing for Crohn's disease, …
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis [NA]
A completed clinical trial evaluated how circadian misalignment affects colonic barrier homeostasis in ulcerative colitis, with the results …
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis [Phase 2, Phase 3]
Clinical trial update reporting that a Phase 2/3 study evaluating nifuroxazide for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Atorvastatin in Patients With Ulcerative Colitis [Phase 2]
This is a Phase 2 trial evaluating atorvastatin in patients with ulcerative colitis. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial of pentoxifylline as adjunctive therapy for ulcerative colitis has completed. The record notes completion but does no…